How do you pay?

How to pay the least

Ask for the cash price

Komzifti

We didn’t find one.

  1. Ask your pharmacy for Komzifti’s cash price, and one or two other pharmacies too.
  2. Komzifti’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameKomzifti
Authorized genericziftomenib
Regular genericziftomenib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Komzifti?
The original
–
–

Brand nameThe maker’s card

KOMZIFTI Copay Card

Savings card from Kura Oncology

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

Sign up on komzifti.com 

In the maker’s words

“Eligible commercially insured patients may utilize KOMZIFTI Copay Support and pay as little as $0. Ask the pharmacist for details.”

From the maker’s offer on komzifti.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Komzifti itself, from the same company, sold without the brand name, and usually for less. For now Komzifti is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

KOMZIFTI is a menin inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1) mutation who have no satisfactory alternative treatment options.

Source: the FDA label for Komzifti (Kura Oncology, Inc.), December 9, 2025. Full label on DailyMed 

Good to know